SCHEMBL13367487

SCHEMBL13367487

CN(c1ccc(C(C)(C)C)cc1)c1ccc2ccccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 2/20 0.54
MAPT P10636 2/20 0.44
MCHR1 Q99705 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 2/20 0.39
HIF1A Q16665 1/20 0.39
DHFR P00374 2/20 0.38
CNR2 P34972 1/20 0.38
PTK2 Q05397 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
TNF P01375 1/20 0.38
NOD1 Q9Y239 1/20 0.38
TRPV1 Q8NER1 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13557858 0.83 NCF1 (0.66) NCF1MAPTMCHR1MEN1KMT2A
SCHEMBL13367555 0.82 NCF1 (0.59) NCF1MAPTMEN1KMT2AKDM4E
SCHEMBL13338168 0.81 NCF1 (0.58) NCF1MAPTMEN1KMT2AKDM4E
SCHEMBL10913638 0.81 NCF1 (0.58) NCF1MAPTMEN1KMT2AKDM4E
SCHEMBL13338566 0.81 NCF1 (0.46) NCF1MAPTMEN1KMT2AKDM4E
SCHEMBL12383278 0.79 NCF1 (0.76) NCF1MAPTMEN1KMT2AKDM4E
SCHEMBL13367445 0.79 NCF1 (0.59) NCF1MAPTMEN1KMT2AKDM4E
SCHEMBL13557864 0.79 NCF1 (0.59) NCF1MAPTMEN1KMT2AKDM4E
SCHEMBL13557868 0.75 NCF1 (0.63) NCF1MAPTMEN1KMT2AKDM4E
SCHEMBL13338170 0.74 NCF1 (0.53) NCF1MAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 NCF1 2193/4885MAPT 3478/4885MCHR1 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.